Pitaya‐Inspired Metal‐Organic Framework Nanozyme for Multimodal Imaging‐Guided Synergistic Cuproptosis, Nanocatalytic Therapy, and Photothermal Therapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202402915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Quer Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Phys…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Photothermal Therapy, Copper, Multimodal Imaging. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Strategic Priority Research Program.
Abstract (Originalsprache)
Nature often provides invaluable insights into technological innovation and the construction of nanomaterials. Inspired by the pitaya fruit's strategy of wrapping seeds within its pulp to enhance seed survival, a unique nanocomposite based on metal‐organic framework (MOF)‐encapsulated CuS nanoparticles (NPs) is developed. This design effectively addresses the challenge of short retention time afforded by CuS NPs for therapeutic and imaging purposes. The MOF acts as the “pitaya pulp” protecting the internal CuS NPs (“pitaya seeds”), thereby increasing their retention time in vivo. This system exhibits triple‐enzyme‐mimicking activities and is proposed for application in photoacoustic and magnetic resonance imaging‐guided therapies, including chemodynamic therapy, photothermal therapy, and cuproptosis‐related therapy. The exceptional enzyme‐mimicking activities of superoxide dismutase, catalase, and peroxidase not only produce oxygen to alleviate hypoxia but also generate a reactive oxygen species (ROS) storm for effective tumor destruction. By combining these multienzymatic properties, superior photothermal performance, and Cu‐induced cuproptosis, nanozyme‐treated mice exhibited an 84% inhibition of tumor growth—approximately double the effect observed in mice treated with CuS NPs alone. This study presents a smart strategy for integrating imaging with therapeutic modalities, achieving exceptional outcomes for precise imaging‐guided tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Scie…
- University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
- School of Biomedical Engineering, Hainan University, Haikou, 570228, P. R. China.
ORCID-Profile: Xin Zhou
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Strategic Priority Research Program
- Key Research Program of Frontier Sciences, CAS
- Hubei Provincial Key Technology Foundation of China
- Major Program (JD) of Hubei Province
- CAS Youth Interdisciplinary Team
- Youth Innovation Promotion Association, CAS
Zitieren
APA
Yue, Q., Zeng, Q., Guo, Q., Zhao, X., Yuan, Y., Yang, Y., Jiang, W., & Zhou, X. (2024). Pitaya‐Inspired Metal‐Organic Framework Nanozyme for Multimodal Imaging‐Guided Synergistic Cuproptosis, Nanocatalytic Therapy, and Photothermal Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402915
Vancouver
Yue Q, Zeng Q, Guo Q, Zhao X, Yuan Y, Yang Y, et al. Pitaya‐Inspired Metal‐Organic Framework Nanozyme for Multimodal Imaging‐Guided Synergistic Cuproptosis, Nanocatalytic Therapy, and Photothermal Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402915
BibTeX
@article{Yue2024,
author = {Yue, Quer and Zeng, Qingbin and Guo, Qianni and Zhao, Xiuchao and Yuan, Yaping and Yang, Yuqi and Jiang, Weiping and Zhou, Xin},
title = {Pitaya‐Inspired Metal‐Organic Framework Nanozyme for Multimodal Imaging‐Guided Synergistic Cuproptosis, Nanocatalytic Therapy, and Photothermal Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202402915}
}
EUVIMED